Los Angeles, CALIFORNIA3 Active Studies

Pediatric Cancer Clinical Trials in Los Angeles, CALIFORNIA

Find 3 actively recruiting pediatric cancer clinical trials in Los Angeles, CALIFORNIA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
1,806
Enrolling

Recruiting Pediatric Cancer Studies in Los Angeles

About Pediatric Cancer Clinical Trials in Los Angeles

Pediatric cancers include a wide range of cancers occurring in children and adolescents, with leukemia, brain tumors, and lymphoma being most common. Overall cure rates have improved dramatically to about 80%. Treatment includes chemotherapy, surgery, radiation, and newer immunotherapies.

There are currently 3 pediatric cancer clinical trials recruiting participants in Los Angeles, CALIFORNIA. These studies are seeking a combined 1,806 participants. Research is being sponsored by Children's Oncology Group, Eli Lilly and Company, Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pediatric Cancer Clinical Trials in Los Angeles — FAQ

Are there pediatric cancer clinical trials in Los Angeles?

Yes, there are 3 pediatric cancer clinical trials currently recruiting in Los Angeles, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Los Angeles?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Los Angeles research site will contact you about next steps.

Are clinical trials in Los Angeles free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Los Angeles studies also compensate for your time and travel.

What pediatric cancer treatments are being tested?

The 3 active trials in Los Angeles are testing new therapies including novel drugs, biologics, and treatment approaches for pediatric cancer.

Data updated March 2, 2026 from ClinicalTrials.gov